• Return to Headlines

Progenics Pharm Up 29.0% Since SmarTrend Uptrend Call (PGNX)

By Nick Russo

SmarTrend identified an Uptrend for Progenics Pharm (NASDAQ:PGNX) on February 26th, 2018 at $6.32. In approximately 2 weeks, Progenics Pharm has returned 28.96% as of today's recent price of $8.15.

In the past 52 weeks, Progenics Pharm share prices have been bracketed by a low of $4.00 and a high of $11.72 and are now at $8.15, 104% above that low price. Over the past week, the 200-day moving average (MA) has gone down 1% while the 50-day MA has advanced 1.1%.

Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Progenics Pharm shares.

Log in and add Progenics Pharm (PGNX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights progenics pharm

Ticker(s): PGNX